Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11)

Authors
Publication date
1 February 2016
Publisher
'Academy of Traumatology'

Abstract

International audienceMeeting Abstract: P028 - ACTRIMS Forum, New Orleans, LA, feb 201

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archive Ouverte en Sciences de l'Information et de la Communication

    redirect
    oaioai:HAL:hal-01300794v1
    Last time updated on 29/04/2016

    HAL-Rennes 1

    redirect
    oaioai:HAL:hal-01300794v1
    Last time updated on 09/11/2016